GLPwatch
Pfizer
PFE · GLP-1 products, pipeline, and financials
Approved GLP-1 products (0)
No FDA-approved GLP-1 products from this manufacturer in our data.
Molecules (0)
No GLP-1 molecules attributed to this manufacturer in our data.
Revenue (SEC) SEC EDGAR ↗
| Concept | Period end | Value | Form |
|---|---|---|---|
| Revenue | 2023-12-31 | $50.9B | 10-K |
| Revenue | 2022-12-31 | $91.8B | 10-K |
| Revenue | 2021-12-31 | $81.3B | 10-K |
| Revenue | 2020-12-31 | $41.7B | 10-K |
| Revenue | 2019-12-31 | $40.9B | 10-K |
| Revenue | 2018-12-31 | $53.6B | 10-K |
| Revenue | 2017-12-31 | $52.5B | 10-K |
| Revenue | 2016-12-31 | $52.8B | 10-K |